Akari Therapeutics, Plc Announces ADS Ratio Change From 1-Representing-100 To 1-Representing-2000; Ratio Change Is Expected To Be Effective On August 17, 2023
Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that Akari will change the ratio of its American